Christia vespertilionis
Christia vespertilionis · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Christia vespertilionis is a botanical species known for containing bioactive compounds such as 7-tetradecenal, Aloeemodin-8-monoglucoside, Bruceine I, and Sanjidin B. Scientific investigations have focused on the potential efficacy of various parts of this plant, specifically the leaf, root, and stem, against SARS-CoV-2. Researchers have evaluated several preparations, including aqueous-methanolic stem (AS) extract, methanol extract, methanolic leaf (ML) extract, and methanolic leaves extract (MeCV). These diverse extracts are studied to determine their pharmacological impact on viral conditions. Through these specific preparations, the plant's chemical profile offers significant interest in the search for novel antiviral agents.
- Synonyms
- Hedysarum Vespertilionis · Lourea Vespertilionis
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Leaf · Root
Classification
Common Names
Christia vespertilionis is a fascinating botanical specimen known by a diverse array of names across different cultures. In English-speaking regions, it is frequently referred to as the East Indian Island Pea. Its unique, bat-like appearance has earned it the Japanese moniker ハバビロホオズキ, while the name 蝙蝠草 also highlights its resemblance to a bat. Additionally, some enthusiasts identify the plant as 飛機草, reflecting its striking and dynamic silhouette. These various common names illustrate the widespread recognition and visual charm of this distinctive species.
Sources: Catalogue of Life (COL)
Synonyms
Christia vespertilionis is a botanical species that has been categorized under several different names throughout its taxonomic history. Due to various shifts in classification, it is officially recognized as having the synonym Hedysarum vespertilionis. Additionally, researchers have historically referred to this same plant as Lourea vespertilionis. These overlapping designations highlight the evolving nature of plant nomenclature and scientific study. Understanding these relationships is essential for ensuring accuracy when documenting the species in botanical databases.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Christia vespertilionis is a unique member of the kingdom Plantae that exhibits fascinating biological classifications. Belonging to the class Equisetopsida, this plant plays a specific role within its natural ecosystem. It is further categorized under the order Fabales, which helps scientists understand its evolutionary lineage. Within this order, the species is a part of the diverse family Fabaceae. Ultimately, it is defined by its specific genus, Christia, which distinguishes it from other closely related vegetation.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Christia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Christia vespertilionis is a geographically diverse species with a presence spanning multiple continents and climatic zones. Its range extends across Africa and the Western Indian Ocean, including the island of Mauritius. Within Asia, the plant thrives in temperate regions such as Southeast China and the island of Hainan. It is also well-established in tropical environments, specifically across the Indian Subcontinent in areas like Assam and Bangladesh. This broad distribution highlights the plant's remarkable ability to adapt to varying ecological niches.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Christia vespertilionis is a self-supporting herb characterized by its unique growth form. This botanical structure allows the plant to maintain its upright posture within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Christia vespertilionis is a medicinal plant indigenous to Malaysia that has shown significant potential in the management of diabetes. Recent metabolomics studies have identified several key metabolites within its leaves that contribute to its antidiabetic properties. Specifically, the plant contains linolenic acid and 7-tetradecenal, both of which play roles in its chemical profile. Furthermore, the presence of Aloeemodin-8-monoglucoside, Bruceine I, and Sanjidin B highlights the complex bioactive makeup of the species. These identified compounds serve as promising candidates for the development of new pharmaceutical treatments for glucose regulation.
Conditions
Christia vespertilionis demonstrates significant therapeutic potential through its ability to treat various pathogens and biological conditions. Extracts from the plant have shown effective in vitro activity against Plasmodium falciparum NF-54, specifically through its stems and leaves. In vivo studies further confirm its medicinal value by showing a high level of suppression of parasitaemia in infected subjects. Additionally, the plant offers promising antiviral properties, with its methanolic leaf extract exhibiting the highest effect against SARS-CoV-2. These combined findings highlight the plant's multifaceted role in combating malaria and viral infections.
Preparations
Christia vespertilionis is prepared as an aqueous-methanolic stem (AS) extract to evaluate its potent antiplasmodial potential against Plasmodium falciparum. The plant is also prepared as a methanol extract to assess its antiviral effects against SARS-CoV-2. Additionally, Christia vespertilionis is prepared as a methanolic leaf (ML) extract, which has demonstrated significant activity in antiplasmodial studies. Research further utilizes Christia vespertilionis prepared as a methanolic leaves extract (MeCV) to identify phytochemical compounds like apigenin for molecular docking analysis. These various extraction methods allow for the specialized study of different plant parts and their therapeutic applications.
Parts used
Christia vespertilionis is a medicinal plant that possesses several biologically active components distributed throughout its physical structure. Research indicates that the leaves of this species contain valuable phytochemicals, such as apigenin derivatives, which show potential in fighting SARS-CoV-2 infections. Furthermore, the plant's stem extracts have demonstrated significant antiplasmodial activity against malaria parasites in laboratory settings. The roots also serve as a critical part of the plant used in various chemical investigations to isolate novel bioactive compounds. By utilizing the leaves, stems, and roots, scientists continue to uncover the diverse therapeutic possibilities held within this single species.